Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

838 public trials 301 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

NCT07020117

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Hoag Memorial Hospital Presbyterian Irvine, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Advent Health Medical Group Radiation Oncology at Central Florida Orlando, Florida, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details
Recruiting

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT06841354

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • USA Mitchell Cancer Institute ( Site 0090) Mobile, Alabama, United States
  • Ironwood Cancer & Research Centers ( Site 0036) Chandler, Arizona, United States
  • City of Hope ( Site 0097) Duarte, California, United States
  • City of Hope Lennar Foundation Cancer Center ( Site 0099) Irvine, California, United States
View all 274 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700

Conditions
Breast Diseases, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms, +6 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0066) Gilbert, Arizona, United States
  • Mayo Clinic Cancer Center ( Site 0034) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0035) Tucson, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center ( Site 0055) Burbank, California, United States
View all 321 locations
View Trial Details
Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

NCT07211178

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations
  • Birmingham Hematology Associates Birmingham, Alabama, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Southern Illinois Hospital Services Carbondale, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

NCT05846789

Conditions
Breast Diseases, Breast Neoplasms, ER Positive, HER2 Negative Breast Cancer, +8 more
Locations
  • Emory University Atlanta, Georgia, United States
  • IU Health Joe and Shelly Schwarz Cancer Center Carmel, Indiana, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details

Related conditions